🦊/Investors

Clal Biotechnology Industries

Venture capital

Tel Aviv · Seed–Late Stage · 9 people tracked

Find your way into Clal Biotechnology Industries

988 people in our graph share verified history with the Clal Biotechnology Industries team — schools, employers, funds. One of them is your warm intro.

Yaryna Nychunlockedknows Nufar Malovani · together at Harvard University (overlapped)
×5knows the team · via Harvard University
×6knows the team · via Harvard Business School
Fox Verdict
Sign up to see your fit

Investment thesis

CBI concentrates on the life sciences sector, backing companies that develop proprietary solutions addressing unmet medical needs with significant market potential. It builds and oversees a global portfolio of innovative healthcare ventures, aiming to advance treatments worldwide. As a publicly listed investment firm, CBI identifies and nurtures groundbreaking science-driven businesses from an early stage through their development.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Tel Aviv, IL
Instruments
Equity
Founded
1998
Tracked investments
10
Unicorns
1
IPOs
1
Acquisitions
1

Team · 9 people

from the firm's website & curated & public directories
Bazil Gamzu· Board Member
Gabi Barabash· Board Member

Professor serving as a board member of CBI.

Gad Keren· Board Member

Professor serving as a board member of CBI.

Nufar Malovani· Board Memberin
Tomer Babai· Board Member
Arnon Aharon· Medical Director

Serves as Medical Director at CBI and holds an MD.

What they invest in

from 10 of 10 portfolio companies

Biotech ×8Healthtech ×7Medical Devices ×5Digital Health ×3AI & Machine Learning ×2Hardware ×2

HQs:United States×3Israel×2

Investments · 10 tracked

founders shown can be your intro path
Mediwoundmediwound.comNASDAQ: MDWD

MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.

BiotechHealthtechMedical DevicesYavne

Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Ety Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)

PartnerAvi Fischer· solo GP

Co-investorsDeep InsightGandyr InvestmentsIsrael Biotech FundNew Era Capital Partners

Biokinebiokine.com

BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.

BiotechDigital HealthHealthtechMedical DevicesJerusalem, IL

Amnon Peled(CEO/CSO)Simone Cabilly(Chief Scientist)

PartnerAvi Fischer· solo GP

Colospancolospan.comin

Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches.

BiotechHardwareHealthtechMedical DevicesKfar Saba, IL

Boaz Assaf(CEO)in

PartnerAvi Fischer· solo GP

Co-investorsTriventures

Elicioelicio.comin𝕏

Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.

BiotechHealthtech

PartnerAvi Fischer· solo GP

Fdnafdna.comin𝕏

FDNA develops AI-powered diagnosis and care management tools that help parents, clinicians, and researchers identify developmental delays and rare genetic disorders early.

AI & Machine LearningDigital HealthHealthtechMedical DevicesBoston, US

Moti ShnibergProfessor Lior WolfErik Feingold(Co-Founder and CEO)in

PartnerAvi Fischer· solo GP

Neon Therapeuticsneontherapeutics.com

BiotechCambridge, US

Richard Gaynor, M.D.(Executive Officer)inRobert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)inEric Lander(Director)Hugh Dowd(Executive Officer, Director)

BoardCary Pfeffer, M.D.(Director)

Co-investorsNextech InvestSofinnova VenturesThird Rock Ventures

Pi Cardiapi-cardia.netin𝕏

Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.

HardwareHealthtechMedical Devices

Erez Golan(Founder)in

PartnerAvi Fischer· solo GP

Co-investorsAccelmed PartnersIndaco Venture PartnersSofinnova Partners

Sightdxsightdx.comin

Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.

AI & Machine LearningBiotechDigital Health

Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)

PartnerAvi Fischer· solo GP

Co-investorsEmery CapitalGEOC

Thumbnail for Constellation Pharmaceuticalsin𝕏acquired by Morphosys · Jun 2021 · $1.7B

Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.

BiotechHealthtech

PartnerAvi Fischer· solo GP

Co-investorsExSight VenturesLongitude CapitalTachyon VenturesThe Column Group

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Mnemosyne Pharmaceuticals

Exits · 2

1 IPOs · 1 acquisitions

MediwoundNASDAQ: MDWDThumbnail for Constellation Pharmaceuticalsacq. by Morphosys

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Clal Biotechnology Industries made?
Clal Biotechnology Industries has 10 tracked investments, 2 of which have exited.
What stage does Clal Biotechnology Industries invest at?
Clal Biotechnology Industries invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Clal Biotechnology Industries focus on?
Clal Biotechnology Industries focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Clal Biotechnology Industries located?
Clal Biotechnology Industries is headquartered in Tel Aviv, IL.
Who does Clal Biotechnology Industries co-invest with?
Clal Biotechnology Industries most often shares deals with Indaco Venture Partners, Longitude Capital, New Era Capital Partners, among 14 tracked co-investors.

Images

Clal Biotechnology Industries photo

Similar investors

Featured in lists